Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns

A C Tree¹

Affiliations

Editorial

A C Tree. Clin Oncol (R Coll Radiol). 2019 Dec.

. 2019 Dec;31(12):813-814.

doi: 10.1016/j.clon.2019.07.002. Epub 2019 Jul 17.

A C Tree¹

¹ The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, UK. Electronic address: alison.tree@icr.ac.uk.

No abstract available

Comment on

The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?
Xing D, Siva S, Hanna GG. Xing D, et al. Clin Oncol (R Coll Radiol). 2019 Jul;31(7):432-443. doi: 10.1016/j.clon.2019.04.006. Epub 2019 Apr 17. Clin Oncol (R Coll Radiol). 2019. PMID: 31005381 Review.
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
Patel PH, Palma D, McDonald F, Tree AC. Patel PH, et al. Clin Oncol (R Coll Radiol). 2019 Dec;31(12):824-833. doi: 10.1016/j.clon.2019.05.015. Epub 2019 Jun 8. Clin Oncol (R Coll Radiol). 2019. PMID: 31182289 Free PMC article. Review.
When Should we Irradiate the Primary in Metastatic Lung Cancer?
Shiarli AM, McDonald F, Gomez DR. Shiarli AM, et al. Clin Oncol (R Coll Radiol). 2019 Dec;31(12):815-823. doi: 10.1016/j.clon.2019.07.012. Epub 2019 Aug 2. Clin Oncol (R Coll Radiol). 2019. PMID: 31383534